| NCT04461158 |
CCCR Lupus Patient Navigator Program |
https://ClinicalTrials.gov/show/NCT04461158 |
Enrolling by invitation |
Medical University of South Carolina |
2021-07-10 |
| NCT04184258 |
Treatment of Systemic Lupus Erythematosus With Pooled Allogenic Mesenchymal Stem Cells |
https://ClinicalTrials.gov/show/NCT04184258 |
Recruiting |
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus |
2020-12-31 |
| NCT03933943 |
A Study of LY3361237 in Participants With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03933943 |
Recruiting |
Eli Lilly and Company |
2021-01-14 |
| NCT03920267 |
Long-Term Safety and Efficacy Study of BMS-986165 in Participants With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03920267 |
Recruiting |
Bristol-Myers Squibb |
2022-07-29 |
| NCT03915652 |
Addressing Disparities in Lupus Care Through an Integrated Care Management Program |
https://ClinicalTrials.gov/show/NCT03915652 |
Enrolling by invitation |
Brigham and Women’s Hospital |
2021-01-31 |
| NCT03843125 |
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT03843125 |
Recruiting |
Eli Lilly and Company |
2025-05-30 |
| NCT03616964 |
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03616964 |
Recruiting |
Eli Lilly and Company |
2021-10-15 |
| NCT03616912 |
A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03616912 |
Recruiting |
Eli Lilly and Company |
2021-10-30 |
| NCT03517722 |
A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03517722 |
Recruiting |
Janssen Research & Development, LLC |
2021-01-22 |
| NCT03407482 |
An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03407482 |
Completed |
Genentech, Inc. |
2019-11-20 |
| NCT03312907 |
A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE |
https://ClinicalTrials.gov/show/NCT03312907 |
Active, not recruiting |
GlaxoSmithKline |
2020-05-29 |
| NCT03374618 |
Neutrophil Extracellular Traps in Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT03374618 |
Recruiting |
CHU de Reims |
2021-10-06 |
| NCT03371251 |
Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care |
https://ClinicalTrials.gov/show/NCT03371251 |
Active, not recruiting |
Boston Pharmaceuticals |
2020-08-31 |
| NCT03288324 |
Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus |
https://ClinicalTrials.gov/show/NCT03288324 |
Recruiting |
Children’s Hospital Medical Center, Cincinnati |
2020-12-31 |
| NCT03262727 |
The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients |
https://ClinicalTrials.gov/show/NCT03262727 |
Completed |
Bristol-Myers Squibb |
2017-11-23 |
| NCT03254784 |
A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulation |
https://ClinicalTrials.gov/show/NCT03254784 |
Completed |
Bristol-Myers Squibb |
2017-11-04 |
| NCT03252587 |
An Investigational Study to Evaluate BMS-986165 in Patients With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03252587 |
Active, not recruiting |
Bristol-Myers Squibb |
2021-04-04 |
| NCT03248518 |
Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases |
https://ClinicalTrials.gov/show/NCT03248518 |
Active, not recruiting |
University of Aberdeen |
2020-10-31 |
| NCT03187743 |
Personalised Pharmacological Approach to the Tapering of Corticosteroid Doses in Systemic Lupus Patients Treated With Prednisone |
https://ClinicalTrials.gov/show/NCT03187743 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2021-01-31 |
| NCT03186794 |
Aerobic Exercise in Women With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03186794 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2022-12-31 |
| NCT03171194 |
Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03171194 |
Completed |
Medical University of South Carolina |
2018-04-30 |
| NCT03161483 |
A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03161483 |
Active, not recruiting |
Celgene |
2020-01-21 |
| NCT03159936 |
Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT03159936 |
Recruiting |
Tufts Medical Center |
2020-06-30 |
| NCT03134222 |
Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE) |
https://ClinicalTrials.gov/show/NCT03134222 |
Completed |
Gilead Sciences |
2019-03-13 |
| NCT03122431 |
Relevance of Monitoring Blood and Salivar Levels of Drugs Used in Rheumatic Autoimmune Diseases |
https://ClinicalTrials.gov/show/NCT03122431 |
Recruiting |
University of Sao Paulo General Hospital |
2020-06-01 |
| NCT03103243 |
Pilot Study to Investigate Contemplative Intervention in Lupus Patients |
https://ClinicalTrials.gov/show/NCT03103243 |
Completed |
University of Virginia |
2018-06-04 |
| NCT03093402 |
JBT-101 in Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT03093402 |
Recruiting |
National Institute of Allergy and Infectious Diseases (NIAID) |
2020-12-31 |
| NCT03054259 |
Rituximab Objective Outcome Measures Trial in SLE |
https://ClinicalTrials.gov/show/NCT03054259 |
Recruiting |
University of Leeds |
2020-02-29 |
| NCT03042260 |
Prophylactic Trimethoprim/Sulfamethoxazole to Prevent Severe Infections in Patients With Lupus Erythematous |
https://ClinicalTrials.gov/show/NCT03042260 |
Recruiting |
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran |
2021-02-28 |
| NCT03031925 |
Detection of Annexin A2 in Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03031925 |
Recruiting |
Centre Hospitalier Universitaire, Amiens |
2018-11-09 |
| NCT03030118 |
Study of Anti-Malarials in Incomplete Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03030118 |
Recruiting |
Milton S. Hershey Medical Center |
2021-09-30 |
| NCT03027674 |
Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud |
https://ClinicalTrials.gov/show/NCT03027674 |
Completed |
Pontificia Universidad Catolica de Chile |
2016-08-31 |
| NCT02975336 |
A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT02975336 |
Active, not recruiting |
EMD Serono |
2019-11-27 |
| NCT02962960 |
A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestations |
https://ClinicalTrials.gov/show/NCT02962960 |
Completed |
AstraZeneca |
2018-01-22 |
| NCT02955615 |
ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT02955615 |
Completed |
Iltoo Pharma |
2018-08-27 |
| NCT02953821 |
Acthar Gel for Active Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT02953821 |
Completed |
Mallinckrodt |
2019-07-31 |
| NCT02950714 |
Dissemination of the Lupus Interactive Navigator |
https://ClinicalTrials.gov/show/NCT02950714 |
Completed |
CHU de Quebec-Universite Laval |
2018-07-31 |
| NCT02932137 |
Anti-infection of Low-does IL-2 in SLE |
https://ClinicalTrials.gov/show/NCT02932137 |
Completed |
Peking University People’s Hospital |
2016-12-16 |
| NCT02927457 |
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of GSK2646264 in Cutaneous Lupus Erythematosus Subjects |
https://ClinicalTrials.gov/show/NCT02927457 |
Completed |
GlaxoSmithKline |
2018-06-12 |
| NCT02925351 |
Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases |
https://ClinicalTrials.gov/show/NCT02925351 |
Completed |
Jonsson Comprehensive Cancer Center |
2018-04-30 |
| NCT02922114 |
Comparison of the Clinical Examination and the Joint Ultrasonography in Lupus Patients |
https://ClinicalTrials.gov/show/NCT02922114 |
Completed |
Centre Hospitalier Régional d’Orléans |
2015-03-31 |
| NCT04453215 |
Dental Implant Therapy for Patients With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT04453215 |
Completed |
Istanbul University |
2019-12-23 |
| NCT02885610 |
Study of RC18 Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE) |
https://ClinicalTrials.gov/show/NCT02885610 |
Completed |
RemeGen |
2019-06-11 |
| NCT02875691 |
Effect of Green Tea on Treatment of Lupus |
https://ClinicalTrials.gov/show/NCT02875691 |
Completed |
Ahvaz Jundishapur University of Medical Sciences |
2016-03-31 |
| NCT02847598 |
Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT02847598 |
Completed |
Biogen |
2019-08-28 |
| NCT02842814 |
Prediction of Relapse Risk in Stable Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT02842814 |
Recruiting |
Peking Union Medical College Hospital |
2020-06-30 |
| NCT02822989 |
Using the Cholinergic Anti-Inflammatory Pathway to Treat Systemic Lupus Musculoskeletal Pain |
https://ClinicalTrials.gov/show/NCT02822989 |
Enrolling by invitation |
Northwell Health |
2018-04-30 |
| NCT02804763 |
A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT02804763 |
Completed |
UCB Pharma |
2018-05-31 |
| NCT02799173 |
Determination of the RANKL/Osteoprotegerin Ratio in Patients With Systemic Lupus Erythematosus. Role in Osteoporosis and Cardiovascular Calcification |
https://ClinicalTrials.gov/show/NCT02799173 |
Completed |
Centre Hospitalier Universitaire, Amiens |
2015-07-01 |
| NCT02794285 |
Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT02794285 |
Active, not recruiting |
AstraZeneca |
2021-12-14 |
| NCT02756546 |
Circulating MicroRNAs in Understanding Pathogenesis of Systemic Lupus Erythematosis |
https://ClinicalTrials.gov/show/NCT02756546 |
Completed |
Cairo University |
2015-09-30 |
| NCT02741960 |
The Effect of Metformin on Reducing Lupus Flares |
https://ClinicalTrials.gov/show/NCT02741960 |
Completed |
RenJi Hospital |
2017-12-13 |
| NCT02732470 |
Effect of Qi Gong Training on Quality of Life in Patients With Systemic Lupus Erythematous (LuQi) |
https://ClinicalTrials.gov/show/NCT02732470 |
Completed |
University Hospital, Limoges |
2017-04-10 |
| NCT02725515 |
A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT02725515 |
Completed |
Xencor, Inc. |
2018-07-17 |
| NCT02708095 |
A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT02708095 |
Completed |
Eli Lilly and Company |
2017-10-12 |
| NCT02677688 |
Autologous EBV-specific Cytotoxic T Cells for the Treatment of Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT02677688 |
Active, not recruiting |
Nantes University Hospital |
2021-09-01 |
| NCT02656082 |
Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT02656082 |
Completed |
University of Leeds |
2017-12-31 |
| NCT02653287 |
Lupus Intervention for Fatigue Trial |
https://ClinicalTrials.gov/show/NCT02653287 |
Recruiting |
Northwestern University |
2021-12-31 |
| NCT02633163 |
Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE) |
https://ClinicalTrials.gov/show/NCT02633163 |
Recruiting |
Medical University of South Carolina |
2021-06-30 |
| NCT02631005 |
Walk With Ease Program For Patients With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT02631005 |
Completed |
University of North Carolina, Chapel Hill |
2018-04-30 |
| NCT02618967 |
Single Ascending Dose Study of AMG 570 in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT02618967 |
Completed |
Amgen |
2018-10-22 |
| NCT02609789 |
A Single Ascending Dose Study in Healthy Participants and Multiple Dose Study of JNJ-55920839 in Participants With Mild to Moderate Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT02609789 |
Completed |
Janssen Research & Development, LLC |
2018-09-30 |
| NCT03098823 |
A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE |
https://ClinicalTrials.gov/show/NCT03098823 |
Completed |
Ampel BioSolutions, LLC |
2019-05-28 |
| NCT02908100 |
A Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT02908100 |
Completed |
Genentech, Inc. |
2019-05-28 |
| NCT02554019 |
Proof-of-Concept Study With BT063 in Subjects With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT02554019 |
Completed |
Biotest |
2017-10-25 |
| NCT03393013 |
A Study of KZR-616 in Patients With Systemic Lupus Erythematosus With and Without Nephritis |
https://ClinicalTrials.gov/show/NCT03393013 |
Recruiting |
Kezar Life Sciences, Inc. |
2021-06-30 |
| NCT02537028 |
MSC2364447C Phase 1b in Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT02537028 |
Completed |
EMD Serono |
2016-10-04 |
| NCT02535689 |
Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT02535689 |
Completed |
National Institutes of Health Clinical Center (CC) |
2018-04-26 |
| NCT02524795 |
Omega 3 Fatty Acids and Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT02524795 |
Completed |
Federal University of Minas Gerais |
2012-08-31 |
| NCT02504645 |
A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT02504645 |
Completed |
ImmuPharma |
2018-01-31 |
| NCT02477150 |
Safety and Immunogenicity of a Zoster Vaccine in SLE |
https://ClinicalTrials.gov/show/NCT02477150 |
Completed |
Tuen Mun Hospital |
2018-11-30 |
| NCT02472795 |
Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT02472795 |
Completed |
Idorsia Pharmaceuticals Ltd. |
2017-01-23 |
| NCT02455089 |
Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT02455089 |
Completed |
University Hospital, Grenoble |
2018-02-28 |
| NCT02453880 |
Web-based CBT for Symptoms of Mild-to-Moderate Anxiety and Depression in Youth With Chronic Illness |
https://ClinicalTrials.gov/show/NCT02453880 |
Completed |
Stanford University |
2015-05-31 |
| NCT02446912 |
Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT02446912 |
Completed |
AstraZeneca |
2018-07-17 |
| NCT02446899 |
Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT02446899 |
Completed |
AstraZeneca |
2018-09-27 |
| NCT02443506 |
A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of Single Dose of AMG 623 in Subjects With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT02443506 |
Completed |
Amgen |
2007-04-30 |
| NCT02437890 |
A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT02437890 |
Completed |
Ablynx |
2018-01-31 |
| NCT02429934 |
Abatacept for SLE Arthritis (IM101-330) |
https://ClinicalTrials.gov/show/NCT02429934 |
Recruiting |
University of California, Los Angeles |
2019-08-01 |
| NCT02411136 |
A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of AMG 623 in Subjects With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT02411136 |
Completed |
Amgen |
2007-08-31 |
| NCT02391259 |
A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT02391259 |
Completed |
Amgen |
2011-09-30 |
| NCT02364908 |
Prospective Evaluation of Decision and Compliance With Antimalarials in Patients With Systemic Lupus |
https://ClinicalTrials.gov/show/NCT02364908 |
Completed |
University Hospital, Lille |
2016-11-30 |
| NCT02330250 |
Effectiveness of Pharmaceutical Care in the Adherence of Systemic Lupus Erythematosus Treatment |
https://ClinicalTrials.gov/show/NCT02330250 |
Completed |
Oswaldo Cruz Foundation |
2016-02-29 |
| NCT02321709 |
Multiple Ascending Dose Study To Assess The Safety Profile Of SAR113244 Versus Placebo In Lupus Male And Female Patients |
https://ClinicalTrials.gov/show/NCT02321709 |
Completed |
Sanofi |
2016-03-31 |
| NCT02319525 |
Individualized Patient Decision Making for Treatment Choices Among Minorities With Lupus |
https://ClinicalTrials.gov/show/NCT02319525 |
Completed |
University of Alabama at Birmingham |
2016-11-30 |
| NCT02307643 |
Exploratory Study of MT-1303 in Systemic Lupus Erythematosus Patients |
https://ClinicalTrials.gov/show/NCT02307643 |
Completed |
Mitsubishi Tanabe Pharma Corporation |
2017-05-31 |
| NCT02306629 |
Study to Compare Properties of Epratuzumab When Given as an Injection Under the Skin or Directly Into the Blood |
https://ClinicalTrials.gov/show/NCT02306629 |
Completed |
UCB Pharma |
2015-04-30 |
| NCT02291588 |
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT02291588 |
Completed |
Amgen |
2010-03-31 |
| NCT02284984 |
Synergetic B-cell Immodulation in SLE |
https://ClinicalTrials.gov/show/NCT02284984 |
Completed |
Leiden University Medical Center |
2018-10-31 |
| NCT02281513 |
Activity and Nutrition Trial in Lupus to Energize and Renew |
https://ClinicalTrials.gov/show/NCT02281513 |
Active, not recruiting |
Northwestern University |
2015-04-30 |
| NCT02270957 |
Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches |
https://ClinicalTrials.gov/show/NCT02270957 |
Active, not recruiting |
Oklahoma Medical Research Foundation |
2018-12-31 |
| NCT02265744 |
Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT02265744 |
Completed |
Bristol-Myers Squibb |
2017-10-26 |
| NCT02194400 |
Dose Escalation Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT02194400 |
Completed |
Resolve Therapeutics |
2015-11-30 |
| NCT02185040 |
A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus. |
https://ClinicalTrials.gov/show/NCT02185040 |
Completed |
Celgene |
2018-09-25 |
| NCT02151409 |
Dose-escalation Trial of Anti-C5aR Antibody in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT02151409 |
Completed |
Novo Nordisk A/S |
2009-10-31 |
| NCT02124798 |
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector |
https://ClinicalTrials.gov/show/NCT02124798 |
Completed |
GlaxoSmithKline |
2015-04-13 |
| NCT02119156 |
Belimumab Treatment Holiday and Treatment Re-start Study in Lupus Patients |
https://ClinicalTrials.gov/show/NCT02119156 |
Completed |
GlaxoSmithKline |
2018-12-14 |
| NCT02106897 |
Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Single Doses and Multiple Doses of BIIB059 in Healthy Volunteers and Participants With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT02106897 |
Completed |
Biogen |
2016-05-24 |
| NCT02084238 |
Low-dose IL-2( Interleukin-2) Treatment in SLE |
https://ClinicalTrials.gov/show/NCT02084238 |
Completed |
Peking University People’s Hospital |
2014-11-30 |
| NCT01305746 |
A Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321 |
https://ClinicalTrials.gov/show/NCT01305746 |
Completed |
Anthera Pharmaceuticals |
2013-07-31 |
| NCT01300208 |
To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01300208 |
Completed |
Amgen |
2013-01-01 |
| NCT01294774 |
Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01294774 |
Completed |
Novartis |
2012-10-31 |
| NCT01283139 |
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01283139 |
Completed |
MedImmune LLC |
2013-11-14 |
| NCT01269866 |
Study of Duloxetine in the Reduction of Pain in Patient With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01269866 |
Completed |
Brain Resource Center |
2012-05-31 |
| NCT03742037 |
Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03742037 |
Recruiting |
Idorsia Pharmaceuticals Ltd. |
2021-05-17 |
| NCT03451422 |
Safety and Efficacy of AMG 592 in Subjects With Active Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03451422 |
Recruiting |
Amgen |
2021-06-16 |
| NCT03355482 |
MRI Evaluation Assessing Synovitis to Address the Unmet Need for Reliable Endpoints in SLE |
https://ClinicalTrials.gov/show/NCT03355482 |
Recruiting |
Oklahoma Medical Research Foundation |
2020-12-31 |
| NCT01992666 |
GENetic & Immunologic Abnomalies in Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01992666 |
Completed |
Hospices Civils de Lyon |
2016-10-31 |
| NCT01988506 |
Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases |
https://ClinicalTrials.gov/show/NCT01988506 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2020-08-13 |
| NCT01972568 |
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01972568 |
Completed |
EMD Serono |
2016-04-30 |
| NCT01953835 |
A Two-part Study to Investigate the Interaction and Pharmacokinetics of GSK2586184 |
https://ClinicalTrials.gov/show/NCT01953835 |
Completed |
GlaxoSmithKline |
2014-03-10 |
| NCT01911169 |
Vitamin D to Improve Endothelial Function in SLE |
https://ClinicalTrials.gov/show/NCT01911169 |
Completed |
Medical University of South Carolina |
2014-01-31 |
| NCT01904812 |
Longitudinal Study of Quality of Life and Activity in Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01904812 |
Completed |
Centre Hospitalier Universitaire Dijon |
2015-05-31 |
| NCT01894360 |
A Study to Estimate the Relative Bioavailability, Tolerability and Safety of a Single Dose of Belimumab Self-Administered Subcutaneously (SC) by Healthy Subjects |
https://ClinicalTrials.gov/show/NCT01894360 |
Completed |
GlaxoSmithKline |
2014-05-13 |
| NCT01892748 |
Cholecalciferol Supplementation on Disease Activity, Fatigue and Bone Mass on Juvenile Systemic Lupus Erythematosus. |
https://ClinicalTrials.gov/show/NCT01892748 |
Completed |
University of Sao Paulo |
2013-08-31 |
| NCT01852851 |
Employment and Arthritis: Making it Work |
https://ClinicalTrials.gov/show/NCT01852851 |
Active, not recruiting |
University of British Columbia |
2020-06-30 |
| NCT01841619 |
IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01841619 |
Completed |
University of California, Irvine |
2014-11-30 |
| NCT01838694 |
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE. |
https://ClinicalTrials.gov/show/NCT01838694 |
Completed |
Invion, Inc. |
2015-08-31 |
| NCT01837875 |
Intervention to Improve Quality of Life in African American Lupus Patients |
https://ClinicalTrials.gov/show/NCT01837875 |
Completed |
Medical University of South Carolina |
2016-06-30 |
| NCT01764594 |
Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01764594 |
Completed |
UCB Pharma |
2014-08-31 |
| NCT01753401 |
Acthar for the Treatment of Systemic Lupus Erythematosus (SLE) in Patients With a History of Persistently Active Disease |
https://ClinicalTrials.gov/show/NCT01753401 |
Completed |
Mallinckrodt |
2015-10-31 |
| NCT01753193 |
An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults |
https://ClinicalTrials.gov/show/NCT01753193 |
Completed |
MedImmune LLC |
2018-07-18 |
| NCT01741012 |
Study to Determine if Gardasil Vaccine is Safe and Effective in Lupus Patients |
https://ClinicalTrials.gov/show/NCT01741012 |
Completed |
Wayne State University |
2015-01-31 |
| NCT01705977 |
Belimumab Assessment of Safety in SLE |
https://ClinicalTrials.gov/show/NCT01705977 |
Active, not recruiting |
GlaxoSmithKline |
2018-07-30 |
| NCT01702740 |
A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01702740 |
Completed |
Centocor Research & Development, Inc. |
2009-10-31 |
| NCT01689350 |
A Prospective Study of Cyclophosphamide in Systemic Lupus Erythematosus Treatment |
https://ClinicalTrials.gov/show/NCT01689350 |
Completed |
Sun Yat-sen University |
2013-12-31 |
| NCT01687309 |
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK2586184 and the Effect of Food and Gender |
https://ClinicalTrials.gov/show/NCT01687309 |
Completed |
GlaxoSmithKline |
2012-07-31 |
| NCT01686555 |
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT01686555 |
Completed |
AbbVie |
2015-06-30 |
| NCT01683695 |
Safety Study of AMG 557 in Subjects With Lupus Arthritis |
https://ClinicalTrials.gov/show/NCT01683695 |
Completed |
Amgen |
2016-03-31 |
| NCT01649765 |
Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy |
https://ClinicalTrials.gov/show/NCT01649765 |
Active, not recruiting |
GlaxoSmithKline |
2018-01-24 |
| NCT01632241 |
Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT01632241 |
Completed |
GlaxoSmithKline |
2018-06-18 |
| NCT01629784 |
Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01629784 |
Completed |
Northwestern University |
2013-01-31 |
| NCT01597622 |
BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115 |
https://ClinicalTrials.gov/show/NCT01597622 |
Completed |
GlaxoSmithKline |
2018-09-13 |
| NCT01597492 |
A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT01597492 |
Completed |
GlaxoSmithKline |
2015-09-01 |
| NCT01597050 |
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions |
https://ClinicalTrials.gov/show/NCT01597050 |
Completed |
Rigel Pharmaceuticals |
2013-09-30 |
| NCT01582880 |
Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis |
https://ClinicalTrials.gov/show/NCT01582880 |
Completed |
Massachusetts Eye and Ear Infirmary |
2014-03-31 |
| NCT01559090 |
Safety and Tolerability of Intravenous Dose of MEDI-546 in Japanese Subjects With Systemic Lupus Erythematosus. |
https://ClinicalTrials.gov/show/NCT01559090 |
Completed |
AstraZeneca |
2014-08-19 |
| NCT01551069 |
Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin Lesion |
https://ClinicalTrials.gov/show/NCT01551069 |
Completed |
Sanofi |
2013-12-31 |
| NCT01534403 |
Open Label Extension Study of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE) Subjects |
https://ClinicalTrials.gov/show/NCT01534403 |
Completed |
UCB Pharma |
2015-02-28 |
| NCT01516450 |
Japanese phase1 Study of Belimumab (IV vs SC) |
https://ClinicalTrials.gov/show/NCT01516450 |
Completed |
GlaxoSmithKline |
2012-04-11 |
| NCT01484496 |
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT01484496 |
Completed |
GlaxoSmithKline |
2015-02-13 |
| NCT01474720 |
Zostavax in Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01474720 |
Completed |
Oklahoma Medical Research Foundation |
2012-07-31 |
| NCT01449071 |
Study Evaluating the Pharmacokinetics and Safety of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT01449071 |
Completed |
UCB Pharma |
2013-03-31 |
| NCT01438489 |
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01438489 |
Completed |
MedImmune LLC |
2015-04-30 |
| NCT01425775 |
The Effect of Vitamin D Supplementation on Disease Activity Markers in Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT01425775 |
Completed |
University of Alexandria |
2010-09-30 |
| NCT01408576 |
Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01408576 |
Completed |
UCB Pharma |
2016-02-29 |
| NCT01405196 |
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01405196 |
Completed |
Pfizer |
2014-03-31 |
| NCT01395745 |
CHABLIS-SC1: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01395745 |
Completed |
Anthera Pharmaceuticals |
2016-07-31 |
| NCT01381536 |
Phase I Study of GSK1550188 in Japanese Subjects With Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT01381536 |
Completed |
GlaxoSmithKline |
2010-11-27 |
| NCT01352988 |
Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01352988 |
Completed |
University Hospital Muenster |
2013-10-31 |
| NCT01351662 |
Balancing Lupus Experiences With Stress Strategies |
https://ClinicalTrials.gov/show/NCT01351662 |
Completed |
Medical University of South Carolina |
2011-10-31 |
| NCT01345253 |
GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia |
https://ClinicalTrials.gov/show/NCT01345253 |
Completed |
GlaxoSmithKline |
2015-09-15 |
| NCT01322308 |
Effect of Pioglitazone on Endothelial Function in Premenopausal Women With Uncomplicated Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01322308 |
Completed |
National Heart Institute, Mexico |
2012-01-31 |
| NCT03575156 |
Microparticles’s Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT03575156 |
Recruiting |
University Hospital, Bordeaux |
2021-09-30 |
| NCT04305418 |
Mindfulness- Based Intervention for Systemic Lupus Erythematosus (SLE) Patients |
https://ClinicalTrials.gov/show/NCT04305418 |
Completed |
Bar-Ilan University, Israel |
2018-09-04 |
| NCT04275193 |
The Safety and Efficacy of Zishenqing in Subjects With Active Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT04275193 |
Recruiting |
Shanghai University of Traditional Chinese Medicine |
2022-03-01 |
| NCT04244539 |
Efficacy of High-intensity Laser in Jaccoud’s Arthropathy in Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT04244539 |
Completed |
Jouf University |
2019-10-30 |
| NCT04233164 |
Genomic Effects of Glucocorticoids in Patients With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT04233164 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2024-02-29 |
| NCT04186871 |
Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren’s Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT04186871 |
Recruiting |
Bristol-Myers Squibb |
2022-06-23 |
| NCT04179032 |
Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT04179032 |
Recruiting |
GlaxoSmithKline |
2023-03-08 |
| NCT04136145 |
Single Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy Subjects |
https://ClinicalTrials.gov/show/NCT04136145 |
Completed |
GlaxoSmithKline |
2020-01-14 |
| NCT04128579 |
Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis |
https://ClinicalTrials.gov/show/NCT04128579 |
Recruiting |
Equillium |
2021-06-30 |
| NCT04127747 |
Efficacy of Individualized Rituximab in Maintaining Remission of Moderate and Severe Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT04127747 |
Recruiting |
Second Affiliated Hospital, School of Medicine, Zhejiang University |
2022-12-31 |
| NCT04082416 |
Study of Recombinant Human B Lymphocyte(RC18) Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE) |
https://ClinicalTrials.gov/show/NCT04082416 |
Recruiting |
RemeGen |
2021-10-31 |
| NCT04077684 |
Efficacy and Safety of Low-dose IL-2 in Patients With SLE: a Multicenter, Randomised, Placebo-controlled Trial |
https://ClinicalTrials.gov/show/NCT04077684 |
Recruiting |
Peking University People’s Hospital |
2024-08-31 |
| NCT04058028 |
Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT04058028 |
Active, not recruiting |
Amgen |
2022-11-14 |
| NCT04035265 |
Application of MRI for Musculoskeletal Involvement in SLE |
https://ClinicalTrials.gov/show/NCT04035265 |
Recruiting |
Hospital del Mar |
2020-01-31 |
| NCT03979976 |
Ramipril, Endothelial Function and Endothelial Progenitor Cells in Patients With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03979976 |
Completed |
Federal University of São Paulo |
2013-08-31 |
| NCT03953261 |
Effect of Curcumin on Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03953261 |
Recruiting |
Loma Linda University |
2020-04-01 |
| NCT03951259 |
Safety and Efficacy of SM934 Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03951259 |
Recruiting |
RenJi Hospital |
2020-12-31 |
| NCT03949426 |
Safety, Tolerability and Pharmacokinetics of KPG-818 in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT03949426 |
Completed |
Kangpu Biopharmaceuticals, Ltd. |
2019-09-29 |
| NCT03942718 |
Systemic Lupus Erythematosus Exercise Program |
https://ClinicalTrials.gov/show/NCT03942718 |
Recruiting |
University Medical Center Mainz |
2019-08-01 |
| NCT03938324 |
Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions |
https://ClinicalTrials.gov/show/NCT03938324 |
Recruiting |
Duke University |
2024-02-29 |
| NCT03937856 |
Smartphone Mindfulness Meditation for Patients With Rheumatic Diseases |
https://ClinicalTrials.gov/show/NCT03937856 |
Enrolling by invitation |
Johns Hopkins University |
2021-05-31 |
| NCT03933839 |
Internet-Based Pain Coping Skills Training for Patients With Lupus |
https://ClinicalTrials.gov/show/NCT03933839 |
Completed |
University of North Carolina, Chapel Hill |
2020-04-22 |
| NCT03917797 |
Mesenchymal Stromal Cells (MSC´s) in Renal Lupus |
https://ClinicalTrials.gov/show/NCT03917797 |
Recruiting |
Universidad de los Andes, Chile |
2022-12-31 |
| NCT03878303 |
Study of AC0058TA in Patients With Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT03878303 |
Recruiting |
ACEA Therapeutics, Inc. |
2020-12-31 |
| NCT03866317 |
A Study to Assess the Safety and Efficacy of Secukinumab in Alleviating Symptoms of Discoid Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03866317 |
Recruiting |
Massachusetts General Hospital |
2020-05-31 |
| NCT03845517 |
A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) |
https://ClinicalTrials.gov/show/NCT03845517 |
Recruiting |
Pfizer |
2022-09-07 |
| NCT03817424 |
A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren’s Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis |
https://ClinicalTrials.gov/show/NCT03817424 |
Active, not recruiting |
Viela Bio |
2020-06-30 |
| NCT03816345 |
Nivolumab in Treating Patients With Autoimmune Disorders or Advanced, Metastatic, or Unresectable Cancer |
https://ClinicalTrials.gov/show/NCT03816345 |
Recruiting |
National Cancer Institute (NCI) |
2022-08-31 |
| NCT03802578 |
The Impact of Exercise on Hand Function, Daily Activities Performance and Quality of Life of SLE’ Patients |
https://ClinicalTrials.gov/show/NCT03802578 |
Completed |
National and Kapodistrian University of Athens |
2018-06-30 |
| NCT03747159 |
Synergetic B-cell Immunomodulation in SLE - 2nd Study. |
https://ClinicalTrials.gov/show/NCT03747159 |
Recruiting |
Leiden University Medical Center |
2020-10-31 |
| NCT03746197 |
Interactive Digital Technology to Assess and Improve Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03746197 |
Active, not recruiting |
National Jewish Health |
2019-09-30 |
| NCT03738826 |
Reducing Disparities in Medication Adherence in SLE |
https://ClinicalTrials.gov/show/NCT03738826 |
Active, not recruiting |
Duke University |
2020-06-30 |
| NCT03734055 |
Peer Approaches to Lupus Self-management |
https://ClinicalTrials.gov/show/NCT03734055 |
Recruiting |
Medical University of South Carolina |
2023-06-30 |
| NCT03724916 |
A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT03724916 |
Active, not recruiting |
Takeda |
2021-11-01 |
| NCT03656627 |
Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease |
https://ClinicalTrials.gov/show/NCT03656627 |
Recruiting |
Alliance Foundation Trials, LLC. |
2022-10-31 |
| NCT03656562 |
Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients |
https://ClinicalTrials.gov/show/NCT03656562 |
Recruiting |
Novartis |
2021-08-13 |
| NCT03626311 |
Omega-3 Replacement With Krill Oil in Disease Management of SLE |
https://ClinicalTrials.gov/show/NCT03626311 |
Recruiting |
Aker Biomarine Antarctic AS |
2020-06-30 |
| NCT03618056 |
Evaluating HIV-1 Neutralization Antibody Breadth in Response to HIV gp120 Protein Vaccine in HIV-uninfected Adults With Quiescent Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03618056 |
Active, not recruiting |
National Institute of Allergy and Infectious Diseases (NIAID) |
2020-09-15 |
| NCT03556007 |
A Study of NKTR-358 (LY3471851) in Participants With Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT03556007 |
Completed |
Eli Lilly and Company |
2019-08-29 |
| NCT03541564 |
An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants to Study Electrocardiogram Effects |
https://ClinicalTrials.gov/show/NCT03541564 |
Completed |
Bristol-Myers Squibb |
2018-09-04 |
| NCT03537638 |
Multicomponent Strategy to Implement a Clinical Practice Guideline and Improve Health Outcomes in People With SLE |
https://ClinicalTrials.gov/show/NCT03537638 |
Active, not recruiting |
Servicio Canario de Salud |
2020-12-31 |
| NCT03527472 |
Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03527472 |
Active, not recruiting |
Vanderbilt University Medical Center |
2022-10-31 |
| NCT03492255 |
CYCLONES - CYClophosphamide LOw Dose and No Extra Steroid |
https://ClinicalTrials.gov/show/NCT03492255 |
Recruiting |
University of Sao Paulo General Hospital |
2018-10-30 |
| NCT03427151 |
Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03427151 |
Completed |
ImmuPharma |
2019-02-05 |
| NCT03426384 |
FLARE Lupus Research Study Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03426384 |
Completed |
Mymee Inc. |
2018-09-05 |
| NCT03421184 |
Dietary Phytoestrogens as Risk Factors for Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03421184 |
Recruiting |
University Hospital, Bordeaux |
2020-11-30 |
| NCT01262365 |
Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01262365 |
Completed |
UCB Pharma |
2015-05-31 |
| NCT01261793 |
Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT01261793 |
Completed |
UCB Pharma |
2015-05-31 |
| NCT01769937 |
Open-label Trial of Acthar Gel in Subjects With Moderate to Severe Active Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01769937 |
Completed |
Fiechtner, Justus J., M.D., P.C. |
2013-04-30 |
| NCT01205438 |
A Study of LY2127399 in Participants With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01205438 |
Completed |
Eli Lilly and Company |
2014-08-31 |
| NCT01196091 |
A Study of LY2127399 in Participants With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01196091 |
Completed |
Eli Lilly and Company |
2014-07-31 |
| NCT01170585 |
A Trial of Rosuvastatin in Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01170585 |
Completed |
Imperial College London |
2014-05-31 |
| NCT01162681 |
PEARL-SC Trial: A Study of the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01162681 |
Completed |
Anthera Pharmaceuticals |
2012-04-30 |
| NCT01146444 |
Sunscreens in Patients With Cutaneous Lupus Erythematosus(CLE) |
https://ClinicalTrials.gov/show/NCT01146444 |
Completed |
Spirig Pharma Ltd. |
2011-09-30 |
| NCT01135459 |
A Study to Evaluate the Efficacy and Safety of CEP-33457 in Patients With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01135459 |
Completed |
Teva Pharmaceutical Industries |
2012-01-31 |
| NCT01120652 |
Reducing Depressive Symptoms in Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01120652 |
Completed |
University of Pittsburgh |
2015-06-30 |
| NCT01112215 |
Enteric-coated Mycophenolate Sodium Versus Azathioprine for the Extra-renal Lupus Manifestations |
https://ClinicalTrials.gov/show/NCT01112215 |
Completed |
Hospital Universitari Vall d’Hebron Research Institute |
2015-12-31 |
| NCT01101802 |
Mycophenolate Mofetil in Systemic Lupus Erythematosus (MISSILE) |
https://ClinicalTrials.gov/show/NCT01101802 |
Completed |
Guy’s and St Thomas’ NHS Foundation Trust |
2008-03-31 |
| NCT01093911 |
Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT01093911 |
Completed |
UCB Pharma |
2012-12-31 |
| NCT01085097 |
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT01085097 |
Completed |
Teva Pharmaceutical Industries |
2012-09-30 |
| NCT01085084 |
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Arthritis |
https://ClinicalTrials.gov/show/NCT01085084 |
Completed |
Teva Pharmaceutical Industries |
2012-08-31 |
| NCT01072734 |
Auto-immunity in Lupus Patients After Influenza Vaccine |
https://ClinicalTrials.gov/show/NCT01072734 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2010-01-31 |
| NCT01058343 |
Safety of IFNa Kinoid in Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01058343 |
Completed |
Neovacs |
2011-04-30 |
| NCT01031836 |
A Study to Evaluate Safety and Tolerability of IV or SC Dose of MEDI-545 in Patients With Systemic Lupus Erythematosus. |
https://ClinicalTrials.gov/show/NCT01031836 |
Completed |
AstraZeneca |
2012-11-07 |
| NCT00997100 |
Exploratory Study of Changes in Disease Activity and Biomarkers With ABR-215757 in Patients With Mild Active Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT00997100 |
Completed |
Active Biotech AB |
2010-09-30 |
| NCT00987831 |
Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT00987831 |
Completed |
Oklahoma Medical Research Foundation |
2012-12-31 |
| NCT00979654 |
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Participants With Systemic Lupus Erythematosus or Myositis |
https://ClinicalTrials.gov/show/NCT00979654 |
Completed |
MedImmune LLC |
2015-03-31 |
| NCT00976729 |
NOX-E36 First-in-Human (FIH) Study |
https://ClinicalTrials.gov/show/NCT00976729 |
Completed |
NOXXON Pharma AG |
2009-12-31 |
| NCT00976300 |
Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune Study |
https://ClinicalTrials.gov/show/NCT00976300 |
Completed |
Institute of Rheumatology, Prague |
2008-05-31 |
| NCT00962832 |
A Study to Evaluate the Efficacy and Safety of Rontalizumab in Patients With Moderately to Severely Active Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00962832 |
Completed |
Genentech, Inc. |
2012-01-31 |
| NCT00960362 |
An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT00960362 |
Completed |
Argos Therapeutics |
2011-12-31 |
| NCT02021513 |
Pilot Study - Effect of Omega-3 on Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT02021513 |
Completed |
University of Texas Southwestern Medical Center |
2013-06-30 |
| NCT00911521 |
Immunogenicity and Safety of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients With SLE: a Controlled Study |
https://ClinicalTrials.gov/show/NCT00911521 |
Completed |
Tuen Mun Hospital |
2011-03-31 |
| NCT00858884 |
Libman-Sacks Endocarditis as a Cause of Neuropsychiatric Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00858884 |
Completed |
University of New Mexico |
2012-07-31 |
| NCT02811094 |
LUMIER² Study : LUpus Molecular Immunomonitoring to Evaluate the Risk of Relapse |
https://ClinicalTrials.gov/show/NCT02811094 |
Recruiting |
Assistance Publique Hopitaux De Marseille |
2020-07-31 |
| NCT00828178 |
Efficacy of Fish Oil in Lupus Patients |
https://ClinicalTrials.gov/show/NCT00828178 |
Completed |
Johns Hopkins University |
2011-02-28 |
| NCT02880852 |
Belimumab Phase I Study in Chinese Subjects With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT02880852 |
Completed |
GlaxoSmithKline |
2017-09-08 |
| NCT00815282 |
Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease |
https://ClinicalTrials.gov/show/NCT00815282 |
Completed |
UMC Utrecht |
2015-01-31 |
| NCT03978520 |
A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT03978520 |
Recruiting |
AbbVie |
2021-09-16 |
| NCT04400240 |
Care Coordination Approaches to Learning Lupus Self-management |
https://ClinicalTrials.gov/show/NCT04400240 |
Completed |
Medical University of South Carolina |
2019-12-31 |
| NCT03189017 |
A Phase I Study of ICP-022 in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT03189017 |
Completed |
Innocare Pharma Australia Pty Ltd |
2018-02-05 |
| NCT03334851 |
Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT03334851 |
Recruiting |
Pfizer |
2022-05-27 |
| NCT02988661 |
Women Empowered to Live With Lupus Study |
https://ClinicalTrials.gov/show/NCT02988661 |
Recruiting |
Emory University |
2021-08-31 |
| NCT03107442 |
Exercise and Arterial Stiffness in Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03107442 |
Completed |
Fundación Pública Andaluza para la Investigación Biomédica AndalucÃa Oriental |
2017-07-21 |
| NCT02349061 |
A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT02349061 |
Completed |
Janssen Research & Development, LLC |
2017-05-15 |
| NCT01781611 |
Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT01781611 |
Completed |
Oklahoma Medical Research Foundation |
2017-05-31 |
| NCT01327352 |
Evaluation of the Influence of Food Regimen on Oshadi D Absorption |
https://ClinicalTrials.gov/show/NCT01327352 |
Completed |
Oshadi Drug Administration |
2011-08-31 |
| NCT00786409 |
Immunogenicity and Safety of HPV Vaccine Gardasil in Young Women |
https://ClinicalTrials.gov/show/NCT00786409 |
Completed |
University of Chicago |
2010-08-31 |
| NCT00779194 |
Prospective Study of Rapamycin for the Treatment of SLE |
https://ClinicalTrials.gov/show/NCT00779194 |
Completed |
State University of New York - Upstate Medical University |
2015-12-31 |
| NCT00774943 |
A Study of AMG 557 in Adults With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00774943 |
Completed |
Amgen |
2012-05-31 |
| NCT00774852 |
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT00774852 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2012-12-31 |
| NCT00750971 |
Autologous Stem Cell Transplantation for Refractory Systemic Lupus Erythematosus (ASSIST) |
https://ClinicalTrials.gov/show/NCT00750971 |
Recruiting |
Charite University, Berlin, Germany |
2020-07-31 |
| NCT00731302 |
Aspirin Resistance in Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT00731302 |
Completed |
Vanderbilt University Medical Center |
2017-04-30 |
| NCT00730002 |
Magnetic Resonance Spectroscopy, Perfusion, and Diffusion Tensor Imaging in Neuropsychiatric Lupus |
https://ClinicalTrials.gov/show/NCT00730002 |
Completed |
University of Michigan |
2014-09-30 |
| NCT00724867 |
A Continuation Trial for Subjects With Lupus Who Completed Protocol HGS1006-C1056 in the United States |
https://ClinicalTrials.gov/show/NCT00724867 |
Completed |
GlaxoSmithKline |
2015-03-31 |
| NCT00714116 |
Study Evaluating The SBI-087 In Subjects With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00714116 |
Completed |
Pfizer |
2012-09-30 |
| NCT00712933 |
A Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057 |
https://ClinicalTrials.gov/show/NCT00712933 |
Completed |
GlaxoSmithKline |
2016-12-09 |
| NCT00710021 |
Vitamin D3 in Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00710021 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2011-07-31 |
| NCT00668330 |
Steroid Induced Osteoporosis in Patients With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00668330 |
Completed |
Chinese University of Hong Kong |
2009-05-31 |
| NCT00660881 |
Open-label Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus Patients With Active Disease |
https://ClinicalTrials.gov/show/NCT00660881 |
Completed |
UCB Pharma |
2011-12-31 |
| NCT00657189 |
A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus |
https://ClinicalTrials.gov/show/NCT00657189 |
Completed |
MedImmune LLC |
2010-05-31 |
| NCT00657007 |
Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT00657007 |
Completed |
Human Genome Sciences Inc. |
2003-03-31 |
| NCT00637819 |
Leflunomide in Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00637819 |
Completed |
Sanofi |
NA |
| NCT00633945 |
Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE) |
https://ClinicalTrials.gov/show/NCT00633945 |
Completed |
University of Pennsylvania |
2009-07-31 |
| NCT00626197 |
A Study to Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG) |
https://ClinicalTrials.gov/show/NCT00626197 |
Completed |
Genentech, Inc. |
2009-10-31 |
| NCT00625521 |
Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions |
https://ClinicalTrials.gov/show/NCT00625521 |
Completed |
Astion Pharma A/S |
NA |
| NCT00625157 |
Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2) |
https://ClinicalTrials.gov/show/NCT00625157 |
Completed |
Astion Pharma A/S |
NA |
| NCT00624351 |
Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus (SLE) Patients With Active Disease |
https://ClinicalTrials.gov/show/NCT00624351 |
Completed |
UCB Pharma |
2009-08-31 |
| NCT00624338 |
Atacicept Phase 2/3 in Generalized Systemic Lupus Erythematosus (APRIL-SLE) |
https://ClinicalTrials.gov/show/NCT00624338 |
Completed |
EMD Serono |
2012-04-30 |
| NCT00611663 |
Safety Study of Two Vaccine Strategies in Patients With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00611663 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2014-12-31 |
| NCT00608673 |
Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00608673 |
Completed |
Shahid Beheshti University of Medical Sciences |
2007-07-31 |
| NCT00594932 |
Biomarker-Linked Outcomes of Cellcept in Lupus Arthritis |
https://ClinicalTrials.gov/show/NCT00594932 |
Completed |
Oklahoma Medical Research Foundation |
2008-07-31 |
| NCT00588393 |
FolateScan in Autoimmune Disease |
https://ClinicalTrials.gov/show/NCT00588393 |
Completed |
Mayo Clinic |
2007-12-31 |
| NCT00583362 |
A Continuation Trial for Subjects With Systemic Lupus Erythematosus That Have Completed Protocol LBSL02 |
https://ClinicalTrials.gov/show/NCT00583362 |
Completed |
GlaxoSmithKline |
2016-02-23 |
| NCT00556192 |
Can Targeted Elimination of B-cell Depletion Therapy and/or Combination Therapy on Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00556192 |
Completed |
Chinese University of Hong Kong |
2009-12-31 |
| NCT00541749 |
A Study of rhuMAb IFNalpha in Adults With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00541749 |
Completed |
Genentech, Inc. |
NA |
| NCT00523588 |
Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye Laser |
https://ClinicalTrials.gov/show/NCT00523588 |
Completed |
University of Pennsylvania |
2009-02-28 |
| NCT01176643 |
Development and Evaluation of Modified Yoga in Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT01176643 |
Completed |
McGill University Health Centre/Research Institute of the McGill University Health Centre |
2012-05-31 |
| NCT00519363 |
Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptors |
https://ClinicalTrials.gov/show/NCT00519363 |
Completed |
The Center for Rheumatic Disease, Allergy, & Immunology |
2008-10-31 |
| NCT00493753 |
Feasibility and Safety of Acupuncture for Systemic Lupus |
https://ClinicalTrials.gov/show/NCT00493753 |
Completed |
University of Pittsburgh |
NA |
| NCT00483613 |
Effects of Treatment of Chronic Stress in Patients With Lupus |
https://ClinicalTrials.gov/show/NCT00483613 |
Completed |
University Hospital Virgen de las Nieves |
NA |
| NCT00482989 |
A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00482989 |
Completed |
MedImmune LLC |
2010-07-31 |
| NCT00470522 |
Study of Methotrexate in Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00470522 |
Completed |
University Health Network, Toronto |
NA |
| NCT00418587 |
Vitamin D Therapy in Patients With Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT00418587 |
Completed |
Medical University of South Carolina |
2008-08-31 |
| NCT00417430 |
Efficacy of Faslodex in Treatment of SLE Clinical, Serologic, and Molecular Studies |
https://ClinicalTrials.gov/show/NCT00417430 |
Completed |
The Center for Rheumatic Disease, Allergy, & Immunology |
2006-12-31 |
| NCT00413361 |
The Reduction of Systemic Lupus Erythematosus Flares :Study PLUS |
https://ClinicalTrials.gov/show/NCT00413361 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2011-01-31 |
| NCT00410384 |
A Study of Belimumab in Subjects With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00410384 |
Completed |
Human Genome Sciences Inc. |
2009-09-30 |
| NCT00401141 |
Abnormalities of B Lymphocytes During Systemic Lupus |
https://ClinicalTrials.gov/show/NCT00401141 |
Completed |
University Hospital, Strasbourg, France |
NA |
| NCT00392951 |
Sirolimus for Autoimmune Disease of Blood Cells |
https://ClinicalTrials.gov/show/NCT00392951 |
Completed |
Children’s Hospital of Philadelphia |
2016-02-29 |
| NCT00392093 |
Effect of Hormone Replacement Therapy on Lupus Activity |
https://ClinicalTrials.gov/show/NCT00392093 |
Completed |
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran |
NA |
| NCT00391924 |
Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren’s Syndrome |
https://ClinicalTrials.gov/show/NCT00391924 |
Completed |
UMC Utrecht |
NA |
| NCT00383513 |
Study of Epratuzumab in Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00383513 |
Completed |
UCB Pharma |
2012-01-31 |
| NCT00371501 |
Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00371501 |
Completed |
Tuen Mun Hospital |
2009-12-31 |
| NCT00317681 |
Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE) |
https://ClinicalTrials.gov/show/NCT00317681 |
Completed |
Heinrich-Heine University, Duesseldorf |
NA |
| NCT00299819 |
Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT00299819 |
Completed |
MedImmune LLC |
NA |
| NCT00293072 |
Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis |
https://ClinicalTrials.gov/show/NCT00293072 |
Completed |
Cambridge University Hospitals NHS Foundation Trust |
NA |
| NCT00278538 |
Cyclophosphamide and Rabbit Antithymocyte Globulin (rATG)/Rituximab in Patients With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00278538 |
Completed |
Northwestern University |
2018-12-31 |
| NCT00271934 |
Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study |
https://ClinicalTrials.gov/show/NCT00271934 |
Completed |
Northwestern University |
2007-11-30 |
| NCT00189124 |
Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention |
https://ClinicalTrials.gov/show/NCT00189124 |
Completed |
University of Michigan |
2005-12-31 |
| NCT00181298 |
Memantine in Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00181298 |
Completed |
Johns Hopkins University |
2007-05-31 |
| NCT00155532 |
Skin Denervation in Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00155532 |
Completed |
National Taiwan University Hospital |
NA |
| NCT00137969 |
A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00137969 |
Completed |
Genentech, Inc. |
2008-08-25 |
| NCT00125307 |
Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis |
https://ClinicalTrials.gov/show/NCT00125307 |
Completed |
Chinese University of Hong Kong |
2007-10-31 |
| NCT00124514 |
Triptorelin for Ovary Protection in Childhood Onset Lupus |
https://ClinicalTrials.gov/show/NCT00124514 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2014-03-31 |
| NCT00120887 |
Lupus Atherosclerosis Prevention Study |
https://ClinicalTrials.gov/show/NCT00120887 |
Completed |
Johns Hopkins University |
NA |
| NCT00119678 |
Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone |
https://ClinicalTrials.gov/show/NCT00119678 |
Completed |
Bristol-Myers Squibb |
2008-11-30 |
| NCT00094380 |
Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077) |
https://ClinicalTrials.gov/show/NCT00094380 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2006-01-31 |
| NCT00082511 |
GL701 (Prestaraâ„¢) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids |
https://ClinicalTrials.gov/show/NCT00082511 |
Completed |
Genelabs Technologies |
2005-08-31 |
| NCT00076752 |
Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00076752 |
Completed |
National Institutes of Health Clinical Center (CC) |
2013-10-15 |
| NCT00071487 |
Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT00071487 |
Completed |
Human Genome Sciences Inc. |
2005-08-31 |
| NCT00065806 |
Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) |
https://ClinicalTrials.gov/show/NCT00065806 |
Completed |
Duke University |
2009-12-31 |
| NCT00054938 |
Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE) |
https://ClinicalTrials.gov/show/NCT00054938 |
Completed |
Brigham and Women’s Hospital |
2005-12-31 |
| NCT00818948 |
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis |
https://ClinicalTrials.gov/show/NCT00818948 |
Completed |
Amgen |
2014-06-30 |
| NCT00001680 |
A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00001680 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00046774 |
Monoclonal Antibody Treatment for Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00046774 |
Completed |
National Institutes of Health Clinical Center (CC) |
2007-01-01 |
| NCT00036491 |
Anti-CD20 in Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00036491 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2006-01-31 |
| NCT00035308 |
Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease |
https://ClinicalTrials.gov/show/NCT00035308 |
Completed |
La Jolla Pharmaceutical Company |
NA |
| NCT00025818 |
Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT00025818 |
Completed |
Allergan |
2003-03-31 |
| NCT00723671 |
Magnetic Resonance Spectroscopy, Perfusion and Diffusion Tensor Imaging in Neuropsychiatric Lupus |
https://ClinicalTrials.gov/show/NCT00723671 |
Completed |
University of Michigan |
2013-04-30 |
| NCT00424476 |
A Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT00424476 |
Completed |
Human Genome Sciences Inc. |
2009-05-31 |
| NCT00011908 |
Humanized LL2IGG to Treat Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00011908 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00010400 |
Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome |
https://ClinicalTrials.gov/show/NCT00010400 |
Completed |
Office of Rare Diseases (ORD) |
NA |
| NCT00010335 |
Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders |
https://ClinicalTrials.gov/show/NCT00010335 |
Completed |
Fred Hutchinson Cancer Research Center |
2010-07-31 |
| NCT00006133 |
Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00006133 |
Completed |
National Center for Research Resources (NCRR) |
NA |
| NCT00005778 |
High-Dose Intravenous (IV) Cyclophosphamide Versus Monthly IV Cyclophosphamide |
https://ClinicalTrials.gov/show/NCT00005778 |
Completed |
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) |
2006-04-30 |
| NCT00004795 |
Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Mild to Moderate Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00004795 |
Completed |
Office of Rare Diseases (ORD) |
NA |
| NCT00004756 |
Study of Individualized Instruction Versus Pamphlet in Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00004756 |
Completed |
Office of Rare Diseases (ORD) |
NA |
| NCT00004665 |
Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00004665 |
Completed |
Office of Rare Diseases (ORD) |
NA |
| NCT00004662 |
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00004662 |
Completed |
Office of Rare Diseases (ORD) |
NA |
| NCT00004643 |
Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00004643 |
Completed |
Office of Rare Diseases (ORD) |
NA |
| NCT00001676 |
Cyclophosphamide and Fludarabine to Treat Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT00001676 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001212 |
Drug Therapy in Lupus Nephropathy |
https://ClinicalTrials.gov/show/NCT00001212 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00000421 |
Serologically Active, Clinically Stable Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT00000421 |
Completed |
NYU Langone Health |
2002-08-31 |
| NCT00000420 |
Safety of Estrogens in Lupus: Birth Control Pills |
https://ClinicalTrials.gov/show/NCT00000420 |
Completed |
NYU Langone Health |
NA |
| NCT00000417 |
Psychoeducational Approach to Improve Health in Lupus |
https://ClinicalTrials.gov/show/NCT00000417 |
Completed |
Brigham and Women’s Hospital |
2001-03-31 |
| NCT00000416 |
Prevention of Arthritis-Related Work Disability |
https://ClinicalTrials.gov/show/NCT00000416 |
Completed |
Boston University Charles River Campus |
2001-08-31 |